Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Feo

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Dermatology Practical & Conceptual|August 9, 2024
Cutaneous Signs of Breast Cancer: When a Dermatologic Evaluation is Useful After a Negative MammographyNello Tommasino, Federica Feo, Mariateresa Cantelli, et al.
The Australasian Journal of Dermatology|April 28, 2023
A case of multiple basal cell carcinomas in an immunocompromised skin district: The aetiopathogenetic role of congenital lymphqedemaVincenzo Picone, Alessia Villani, Federica Feo, et al.
Journal of Inflammation Research|February 19, 2026
IL-23 Inhibitors in Psoriasis: What Have We Learnt so Far?Matteo Megna, Michela D'Agostino, Federica Feo, et al.
Clinical and Experimental Dermatology|December 18, 2024
The use of ChatGPT in the dermatological field: a narrative reviewLuca Potestio, Federica Feo, Fabrizio Martora, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 14, 2025
Effectiveness of Janus Kinase Inhibitors for the Management of Atopic Dermatitis and Concomitant Occupational Allergic Contact Dermatitis: A Real-Life StudyLuca Potestio, Cataldo Patruno, Federica Feo, et al.
Italian Journal of Dermatology and Venereology|March 16, 2026
Cutaneous endometriosis mimicking dermatofibrosarcoma protuberans: a dermoscopic pitfallNello Tommasino, Federica Feo, Rosaria Cappiello, et al.
Italian Journal of Dermatology and Venereology|July 23, 2024
ChatGPT and dermatologyMichela D'Agostino, Federica Feo, Fabrizio Martora, et al.
Expert Opinion on Drug Safety|May 3, 2024
Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluationLuca Potestio, Nello Tommasino, Giuseppe Lauletta, et al.
Biomedicines|August 26, 2022
Fluorescent In Situ Staining and Flow Cytometric Procedures as New Pre-Diagnostic Tests for Sialidosis, GM1 Gangliosidosis and Niemann-Pick Type CClaudia Capitini, Federica Feo, Anna Caciotti, et al.
Expert Opinion on Pharmacotherapy|June 25, 2024
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyondAntonio Portarapillo, Luca Potestio, Nello Tommasino, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Dermatology Practical & Conceptual|August 9, 2024
Cutaneous Signs of Breast Cancer: When a Dermatologic Evaluation is Useful After a Negative MammographyNello Tommasino, Federica Feo, Mariateresa Cantelli, et al.
The Australasian Journal of Dermatology|April 28, 2023
A case of multiple basal cell carcinomas in an immunocompromised skin district: The aetiopathogenetic role of congenital lymphqedemaVincenzo Picone, Alessia Villani, Federica Feo, et al.
Journal of Inflammation Research|February 19, 2026
IL-23 Inhibitors in Psoriasis: What Have We Learnt so Far?Matteo Megna, Michela D'Agostino, Federica Feo, et al.
Clinical and Experimental Dermatology|December 18, 2024
The use of ChatGPT in the dermatological field: a narrative reviewLuca Potestio, Federica Feo, Fabrizio Martora, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 14, 2025
Effectiveness of Janus Kinase Inhibitors for the Management of Atopic Dermatitis and Concomitant Occupational Allergic Contact Dermatitis: A Real-Life StudyLuca Potestio, Cataldo Patruno, Federica Feo, et al.
Italian Journal of Dermatology and Venereology|March 16, 2026
Cutaneous endometriosis mimicking dermatofibrosarcoma protuberans: a dermoscopic pitfallNello Tommasino, Federica Feo, Rosaria Cappiello, et al.
Italian Journal of Dermatology and Venereology|July 23, 2024
ChatGPT and dermatologyMichela D'Agostino, Federica Feo, Fabrizio Martora, et al.
Expert Opinion on Drug Safety|May 3, 2024
Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluationLuca Potestio, Nello Tommasino, Giuseppe Lauletta, et al.
Biomedicines|August 26, 2022
Fluorescent In Situ Staining and Flow Cytometric Procedures as New Pre-Diagnostic Tests for Sialidosis, GM1 Gangliosidosis and Niemann-Pick Type CClaudia Capitini, Federica Feo, Anna Caciotti, et al.
Expert Opinion on Pharmacotherapy|June 25, 2024
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyondAntonio Portarapillo, Luca Potestio, Nello Tommasino, et al.
Pageof 2